CareRx (TSE:CRRX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CareRx Corporation reported a mixed financial performance for Q2 2024 with a revenue of $92.0 million and an increased adjusted EBITDA of $7.5 million, despite facing a net loss of $1.4 million. The company remains committed to improving productivity and managing costs, while capitalizing on growth opportunities in the seniors living sector.
For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.
